Trial Profile
A Randomized, Open-label, Single-dose Study to Evaluate the Safety and the Pharmacokinetics After Oral Concurrent Administration of HDDO-16141 and HDDO-16142 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Bazedoxifene/colecalciferol (Primary) ; Bazedoxifene; Colecalciferol
- Indications Osteoporosis
- Focus Pharmacokinetics
- Sponsors Hyundai Pharmaceutical
- 15 Mar 2018 New trial record